The report "Surgical Devices Market by Product [Capital Equipment (Robotic Systems, Energy Generators), Endoscopy (Rigid, Flexible), Single-use Consumables, Implants], Procedure (General, Cardiovascular), End User (Hospital, ASCs), Region - Global Forecast to 2031", is projected to grow from USD 188.74 billion in 2026 and to reach USD 296.76 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 9.5% during the forecast period.
Browse 300 market data Tables and 60 Figures spread through 350 Pages and in-depth TOC on "Surgical Devices Market by Product [Capital Equipment (Robotic Systems, Energy Generators), Endoscopy (Rigid, Flexible), Single-use Consumables, Implants], Procedure (General, Cardiovascular), End User (Hospital, ASCs), Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/surgical-devices-market-139889000.html
There is growth in the surgical devices market because of the increase in the number of chronic disease cases, such as cardiovascular disease, cancers, obesity, and orthopedic disease, across the globe. Other factors promoting market growth include the increased use of minimally invasive and robotic-assisted surgeries, the increasing aging population, and the rising demand for precision-based surgical methods. Furthermore, there have been advancements in the field of surgical robots, surgical imaging, navigation, and smart surgical rooms that help improve both the outcome of surgical procedures and the efficiency of operations. There has also been an expansion in the field of healthcare facilities, an increase in healthcare spending, the development of ASCs, and an increased demand for outpatient surgeries.
By type, the soft-tissue surgical devices segment accounted for the largest share of the surgical devices market in 2025.
By type, the surgical devices market is segmented into soft-tissue surgical devices, hard-tissue surgical devices and hybrid platforms. In 2025, the soft-tissue surgical devices segment held the largest share in the market. This is due to their large-scale applications in a number of high-volume surgeries such as general surgery, gastrointestinal surgery, gynecological surgery, urological surgery, cardiovascular surgery, thoracic surgery, and oncology. Various soft tissue surgeries involve an array of instruments like surgical staples, sutures, energy-based instruments, trocars, endoscopes, vascular sealing devices, and hemostasis, causing large-scale use of surgical devices per surgery. Moreover, the increasing use of minimally invasive and robotic surgeries that mainly target soft tissues is driving the demand further. The increasing cases of cancer, obesity, gastrointestinal disorders, and cardiovascular diseases are also responsible for the dominance of this segment in the global market.
By procedure, the orthopedic segment accounted for the largest share of the surgical devices market in 2025.
By procedure, the surgical devices market is segmented into general surgery, gastrointestinal, gynecology, urology, cardiovascular, neurology, orthopedics, ENT, pediatric, dental, and other procedures. In 2025, the orthopedic segment held the largest share in the market. This is due to the high incidence rate of musculoskeletal diseases, osteoarthritis, osteoporosis, sports injuries, fractures, and degenerative conditions across the globe. The increasing number of the aging population is leading to an increased need for orthopedic surgeries such as joint replacement surgery, spine surgery, fixation of bone injuries, and sports injury repair. These procedures require a wide range of high-value surgical devices, which include orthopedic implants, surgical power tools, image guidance systems, and robotic systems. Moreover, the rising trends in sports participation, obesity rates, and developments in implant materials and surgical techniques further boost orthopedic surgery volume.
In 2025, Europe accounted for the second-largest share of the surgical devices market.
The surgical devices market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Europe region holds the second largest share of the market due to the high incidence of chronic disease, increasing elderly population, and the well-developed healthcare system of the region. For instance, according to the statistics provided by the Robert Koch Institute, 53.7% of adults in Germany suffered from chronic diseases or had other health conditions in 2024, thus promoting cardiovascular, orthopedic, neurologic, and general surgical procedures, among others. In addition, GLOBOCAN 2022 revealed the high prevalence of various types of cancers in key European countries, such as Germany (605,805 cases), France (483,568 cases), Italy (436,242 cases), and Spain (278,729). Moreover, the rising number of the geriatric population, with Germany reporting 12.7 million individuals aged 67 years and older in 2024, promotes the use of minimally invasive surgical procedures, implants, and robot-assisted surgery across the region.
Key Market Players
The key players in the global surgical devices market are Medtronic (Ireland), Boston Scientific Corporation (US), B Braun SE (Germany), Johnson& Johnson (US), Stryker (US), Intuitive Surgical Operations, Inc. (US), CONMED Corporation (US), Olympus Corporation (Japan), and others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com